Market Overview

XRP/USD Defends Ascending Channel Support

XRP/USD Defends Ascending Channel Support
  • XRP/USD revamps the trend upwards and technical levels start sending bullish signals.
  • Ripple trends higher within a rising channel; short-term support established at $0.4200.

Ripple is among the cryptocurrencies that are building a bullish momentum following the rejection at $0.46 in the wake of the bull rally from the recent support at $0.36. Many experts had predicted XRP/USD growth above $0.50 in the recent bull rally instead, the price stalled at $0.46; slightly lower than the previous high at $0.47.

Short-Term support has been established at $0.4200. At the same time, the ascending channel lower trendline continues to prevent dips due to the rising volatility on the market. While supported by the 50 Simple Moving Average(SMA) 1-hour, the price has increased in value to exchange hands at $0.442.

The initial resistance for the third largest crypto rests at $0.45. A second hurdle is seen at $0.47 while the supply zone at $0.50 will limit gains. If XRP/USD can correct above $0.47 (previous hurdle), the price could have a clear path to $0.50 resistance and focus on higher levels heading to $0.60.

Meanwhile, the Moving Average Convergence Divergence (MACD) is changing direction upwards to show that the buyers are gaining traction and a formidable reversal expected. The increasing gap between the moving averages also confirms the bullish momentum. In fact, it is just a matter of time before Ripple corrects above $0.45.

XRP/USD 1-hour chart


Posted-In: Bitcoin crypto marketCryptocurrency News Forex Global Markets General


Related Articles

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Amarin's Cardiovascular Fish Oil Pill May Hit Market Sooner: FDA Accords Priority Review Designation

Mid-Morning Market Update: Markets Open Lower; Dicks Sporting Goods Profit Beats Views